- Investing Ideas
- /
- Mexican Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Mexican Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
1
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LAB B | Mex$26.12 | -1.1% | 78.1% | Mex$25.7b | Mex$26.00 | PE15.4x | E19.8% | 3.1% |
Page 1 of 1